| |
No. of patients(%)
|
ERβ Expression
|
χ2
|
p value
|
IL6 Expression
|
χ2
|
p value
|
|---|
|
Positive
|
Negative
|
Positive
|
Negative
|
|---|
|
All
|
289
|
258
|
31
| | |
270
|
19
| | |
|
Gender
|
|
Female
|
102(35.29)
|
95
|
7
|
2.458
|
0.117
|
99
|
3
|
3.388
|
0.066
|
|
Male
|
187(64.71)
|
163
|
24
| | |
171
|
16
| | |
|
Age
|
|
< 60
|
170(58.82)
|
150
|
20
|
0.465
|
0.495
|
158
|
12
|
0.158
|
0.691
|
|
≥ 60
|
119(41.18)
|
108
|
11
| | |
112
|
7
| | |
|
Smoking
|
|
Ex
|
178(61.59)
|
162
|
16
|
1.462
|
0.227
|
171
|
7
|
5.266
|
0.022
|
|
Never
|
111(38.41)
|
96
|
15
| | |
99
|
12
| | |
|
T stage
|
|
1a-2b
|
220 (76.12)
|
194
|
26
|
1.146
|
0.284
|
205
|
15
|
0.089
|
0.765
|
|
3–4
|
69 (23.88)
|
64
|
5
| | |
65
|
4
| | |
|
Lymph node metastasis
|
|
YES
|
187(64.71)
|
167
|
20
|
0.001
|
0.974
|
178
|
9
|
2.677
|
0.102
|
|
NO
|
102(35.29)
|
91
|
11
| | |
92
|
10
| | |
|
Metastasis
|
|
YES
|
24(08.30)
|
18
|
6
|
5.568
|
0.018
|
20
|
4
|
4.34
|
0.037
|
|
NO
|
265(91.70)
|
240
|
25
| | |
250
|
15
| | |
|
TNM stage
|
|
I-II
|
175 (60.55)
|
154
|
21
|
0.751
|
0.386
|
162
|
13
|
0.527
|
0.468
|
|
III-IV
|
114(39.45)
|
104
|
10
| | |
108
|
6
| | |
|
Tumor Histology
|
|
SQC
|
134(46.37)
|
115
|
19
|
3.11
|
0.078
|
125
|
9
|
0.008
|
0.92873
|
|
ADC
|
155(53.63)
|
143
|
12
| | |
145
|
10
| | |
|
Tumor Differentation
|
|
Well/Moderate
|
156(53.98)
|
134
|
22
|
4.034
|
0.045
|
141
|
15
|
5.104
|
0.024
|
|
Poor
|
133(46.02)
|
124
|
9
| | |
129
|
4
| | |
- P values listed are derived from χ2 test
